Syndros THC Oral Solution Now FDA Approved Schedule II
The U.S. Drug Enforcement Administration has placed the Syndros THC oral solution under Schedule II via FDA Approval.
Syndros, a drug product consisting of dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] oral solution has been deemed a FDA-approved product of oral solutions containing dronabinol in schedule II of the CSA..
Plus, Supreme Court nominee Neil Gorsuch thinks corps have more religious rights than marijuana worshippers. The cannabis industry is bullish despite Attorney General Jeff Sessions’ reefer madness. Plus, Russ speaks with Hemp expert Anndrea Hermann, which was conducted last summer in Vancouver, British Columbia. Plus, How medical cannabis and industrial hemp advocates unknowingly harm legalization.